262 related articles for article (PubMed ID: 12390692)
1. Role of p38 mitogen-activated protein kinase in lipopolysaccharide-induced expression of inducible nitric oxide synthase in human endothelial cells.
Kan WH; Yan WS; Jiang Y; Wang JZ; Qin QH; Zhao KS
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):388-92. PubMed ID: 12390692
[TBL] [Abstract][Full Text] [Related]
2. Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression.
Kan W; Zhao KS; Jiang Y; Yan W; Huang Q; Wang J; Qin Q; Huang X; Wang S
Shock; 2004 Mar; 21(3):281-7. PubMed ID: 14770043
[TBL] [Abstract][Full Text] [Related]
3. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production.
Lahti A; Kankaanranta H; Moilanen E
Eur J Pharmacol; 2002 Nov; 454(2-3):115-23. PubMed ID: 12421638
[TBL] [Abstract][Full Text] [Related]
4. p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells.
Huang H; Rose JL; Hoyt DG
Mol Pharmacol; 2004 Aug; 66(2):302-11. PubMed ID: 15266021
[TBL] [Abstract][Full Text] [Related]
5. p38 mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells.
Han IO; Kim KW; Ryu JH; Kim WK
Neurosci Lett; 2002 May; 325(1):9-12. PubMed ID: 12023055
[TBL] [Abstract][Full Text] [Related]
6. Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide.
Yan W; Zhao K; Jiang Y; Huang Q; Wang J; Kan W; Wang S
Shock; 2002 May; 17(5):433-8. PubMed ID: 12022767
[TBL] [Abstract][Full Text] [Related]
7. Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells.
Won JS; Lee JK; Suh HW
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):1-10. PubMed ID: 11311970
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts.
Chae HJ; Kim SC; Chae SW; An NH; Kim HH; Lee ZH; Kim HR
Pharmacol Res; 2001 Mar; 43(3):275-83. PubMed ID: 11401420
[TBL] [Abstract][Full Text] [Related]
9. [Advanced glycation end products inhibit production of nitric oxide by human endothelial cells through activation of the p38 signal pathway].
Guo Z; Hou F; Zhang X; Liu Z; Wang L
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1328-31. PubMed ID: 12509937
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.
Bhat NR; Zhang P; Lee JC; Hogan EL
J Neurosci; 1998 Mar; 18(5):1633-41. PubMed ID: 9464988
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells.
Baydoun AR; Wileman SM; Wheeler-Jones CP; Marber MS; Mann GE; Pearson JD; Closs EI
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):265-72. PubMed ID: 10548560
[TBL] [Abstract][Full Text] [Related]
13. [The role of p38 MAPK in LPS induced ICAM-1 expression on endothelial cell].
Yan W; Jiang Y; Huang Q
Zhonghua Shao Shang Za Zhi; 2001 Feb; 17(1):32-5. PubMed ID: 11876908
[TBL] [Abstract][Full Text] [Related]
14. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 mitogen-activated protein kinase activation.
Bhat NR; Zhang P; Bhat AN
J Neurochem; 1999 Feb; 72(2):472-8. PubMed ID: 9930718
[TBL] [Abstract][Full Text] [Related]
15. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes.
Badger AM; Cook MN; Lark MW; Newman-Tarr TM; Swift BA; Nelson AH; Barone FC; Kumar S
J Immunol; 1998 Jul; 161(1):467-73. PubMed ID: 9647257
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma.
Ajizian SJ; English BK; Meals EA
J Infect Dis; 1999 Apr; 179(4):939-44. PubMed ID: 10068590
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression.
Kim SH; Kim J; Sharma RP
Pharmacol Res; 2004 May; 49(5):433-9. PubMed ID: 14998552
[TBL] [Abstract][Full Text] [Related]
18. Effects of taraxasterol on iNOS and COX-2 expression in LPS-induced RAW 264.7 macrophages.
Xiong H; Cheng Y; Zhang X; Zhang X
J Ethnopharmacol; 2014 Aug; 155(1):753-7. PubMed ID: 24945401
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p38 MAP Kinase in the inhibitory effects of phosphatidylserine liposomes on nitric oxide production from macrophages stimulated with LPS.
Aramaki Y; Matsuno R; Tsuchiya S
Biochem Biophys Res Commun; 2001 Feb; 280(4):982-7. PubMed ID: 11162622
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
Lahti A; Sareila O; Kankaanranta H; Moilanen E
BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
